Clinical Trial Update: Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects [Phase 4]

View source ↗

Summary

Phase 4 study evaluating a thermostable formulation of FLOLAN (epoprostenol) in Japanese patients with pulmonary arterial hypertension, with results reported af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• FLOLAN (EPOPROSTENOL SODIUM)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-04-06